chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy test, Pruritus, Urticaria
Clinical narrative: hives all over the body; I had ithcy hands, palms, and itchniess all over body.; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 022MZ0A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.   On 17-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEK) (oral) ongoing from 15-Apr-2021 for Pruritus and Hives, at a dose of 10 mg once a day and PREDNISONE (oral) from 09-Apr-2021 to 12-Apr-2021 for Pruritus and Hives, at a dose of UNK, bid. At the time of the report, URTICARIA (hives all over the body) and PRURITUS (I had ithcy hands, palms, and itchniess all over body.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Allergy test: negative (Negative) My food allergy testing came back negative.         Concomitant product use was not provided by the reporter.  The patient reported that he attempted to stop taking the Zyrtek, but when he does, the itchiness and hives returns.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Initial additional included significant update: new event, allergy history, lab test
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypersomnia, Myalgia, Vomiting
Clinical narrative: achy; sleeping a lot; headache; chills; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), VOMITING (Vomiting), MYALGIA (achy), HYPERSOMNIA (sleeping a lot) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048a21a and 023m20a) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus (type 1 diabetic.).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 09-Apr-2021, the patient experienced CHILLS (chills), VOMITING (Vomiting) and HEADACHE (headache). On 10-Apr-2021, the patient experienced MYALGIA (achy) and HYPERSOMNIA (sleeping a lot). On 10-Apr-2021, CHILLS (chills), VOMITING (Vomiting), MYALGIA (achy) and HYPERSOMNIA (sleeping a lot) outcome was unknown. On 11-Apr-2021, HEADACHE (headache) outcome was unknown.            Blood sugar 99 when vomiting. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. CONCOMITANT PRODUCT IS NOT PROVIDED. TREATMENT IS NOT PROVIDED.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Lymph node pain, Lymphadenopathy, Nodule, Vaccination site reaction
Clinical narrative: lymph nodes are still swollen; lymph nodes are still sore; lump on her arm pit; Nodules armpit area; minor injection site reactions; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (lump on her arm pit), VACCINATION SITE REACTION (minor injection site reactions), NODULE (Nodules armpit area), LYMPHADENOPATHY (lymph nodes are still swollen) and LYMPH NODE PAIN (lymph nodes are still sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included Ovarian tumor benign and Oophorectomy unilateral (removal of  one ovary due to tumor at age 40.). Concurrent medical conditions included Hot flashes (every 7 minutes began after removal of  one ovary). Concomitant products included ESTROGEN NOS;PROGESTERONE;TESTOSTERONE from 01-Sep-2004 to an unknown date for Hot flashes, Hormone replacement therapy and Oophorectomy unilateral.    On 04-Apr-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced NODULE (Nodules armpit area). On 10-Apr-2021, the patient experienced AXILLARY MASS (lump on her arm pit). In April 2021, the patient experienced VACCINATION SITE REACTION (minor injection site reactions). On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes are still swollen) and LYMPH NODE PAIN (lymph nodes are still sore). At the time of the report, AXILLARY MASS (lump on her arm pit), VACCINATION SITE REACTION (minor injection site reactions), NODULE (Nodules armpit area), LYMPHADENOPATHY (lymph nodes are still swollen) and LYMPH NODE PAIN (lymph nodes are still sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Bilateral mammogram, ultrasound  was done before the 2nd shot due to nodules inflamation throughout the arm of vaccine side. No treatment information was provided. Soreness and vaccination site inflammation started 3-5 days after vaccination and remained for 40-50 days. Mammogram of the left side was suggested by the doctor but patient did not want to get it done .   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant Follow document received  contain new event updated  (Lymph node still sore ) and lab data is added.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: headache; fever 101.5°; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever 101.5°) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A/4 and 003AHA) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced HEADACHE (headache), PYREXIA (fever 101.5°) and CHILLS (chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PREDNISONE at a dose of Heavy dose. At the time of the report, HEADACHE (headache), PYREXIA (fever 101.5°) and CHILLS (chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 101.5 (High) fever 101.5°.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was Not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-074749 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Peripheral swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: arm is swollen; red and itchy at the site of injection; red and itchy at the site of injection; It was sore; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE PRURITUS (red and itchy at the site of injection), INJECTION SITE PAIN (It was sore) and VACCINATION SITE ERYTHEMA (red and itchy at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE PRURITUS (red and itchy at the site of injection) and VACCINATION SITE ERYTHEMA (red and itchy at the site of injection). In April 2021, the patient experienced INJECTION SITE PAIN (It was sore). At the time of the report, PERIPHERAL SWELLING (arm is swollen), VACCINATION SITE PRURITUS (red and itchy at the site of injection) and VACCINATION SITE ERYTHEMA (red and itchy at the site of injection) outcome was unknown and INJECTION SITE PAIN (It was sore) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Myalgia, Pyrexia, Tonsillitis
Clinical narrative: dizziness; severe tonsillitis; intermittent low grade fever; severe muscle aches; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (dizziness), TONSILLITIS (severe tonsillitis), PYREXIA (intermittent low grade fever) and MYALGIA (severe muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced MYALGIA (severe muscle aches). On an unknown date, the patient experienced DIZZINESS (dizziness), TONSILLITIS (severe tonsillitis) and PYREXIA (intermittent low grade fever). The patient was treated with Bed rest for Dizziness; Bed rest for Tonsillitis; Bed rest for Pyrexia and Bed rest for Myalgia. At the time of the report, DIZZINESS (dizziness), TONSILLITIS (severe tonsillitis), PYREXIA (intermittent low grade fever) and MYALGIA (severe muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Heart rate: 100 (High) increased heart rate to 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Reporter mentioned that the patient had adverse reactions for 2 weeks and had to be in bed. Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Pityriasis rosea, Specialist consultation
Clinical narrative: diagnosis of Pityriasis Rosia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PITYRIASIS ROSEA (diagnosis of Pityriasis Rosia) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heartburn, Blood pressure abnormal and Blood cholesterol abnormal. Concurrent medical conditions included Osteoporosis. Concomitant products included AMLODIPINE for Blood pressure abnormal, EZETIMIBE for Cholesterol, DEXLANSOPRAZOLE (DEXILANT) for Heartburn, ALENDRONATE SODIUM (ALENDRONATE) for Osteoporosis, LOSARTAN, ACETYLSALICYLIC ACID (ASPIRIN 81), ROSUVASTATIN and METOPROLOL for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PITYRIASIS ROSEA (diagnosis of Pityriasis Rosia). The patient was treated with HYDROCORTISONE (topical) for Adverse event, at an unspecified dose and frequency. At the time of the report, PITYRIASIS ROSEA (diagnosis of Pityriasis Rosia) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Specialist consultation: pityriasis rosia (abnormal) diagnosis of Pityriasis Rosia. On an unknown date, Biopsy: pityriasis rosia (abnormal) Underwent biopsy of the red lesion.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PITYRIASIS ROSEA (diagnosis of Pityriasis Rosia) to be not related.    On 24FEB2021, the patient noticed red spots over the wrists, both legs, upper thigs, stomach and back since 24Feb2021. On 28FEB2021, she developed red spots on her arm. On 14MAR2021, the patient went to receive the 2nd dose and the vaccination center did not give the 2nd shot after patient showed the red spots on her arms and was advised to consult the HCP. Patient did consulted the HCP and did some blood work and reports came back normal and HCP mentioned as no idea what are those red spots and where they came from. Patient then consulted the dermatologist , who prescribed hydrocortisone cream and the red spots did not get better, so 2 weeks later she underwent biopsy of those red lesion and  report came as diagnosis of Pityriasis Rosia. Dermatologist said that it could be related to Moderna vaccine. Also mentioned that, it would take 3 months more to disappear .   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Initial additional document added: event details were added.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular, Ovulation pain, Pain in extremity
Clinical narrative: period was abundant, with too much bleeding; period was very painful; her period came a week earlier; pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the left arm), HEAVY MENSTRUAL BLEEDING (period was abundant, with too much bleeding), OVULATION PAIN (period was very painful) and MENSTRUATION IRREGULAR (her period came a week earlier) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the left arm). On 31-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (period was abundant, with too much bleeding), OVULATION PAIN (period was very painful) and MENSTRUATION IRREGULAR (her period came a week earlier). On 09-Apr-2021, HEAVY MENSTRUAL BLEEDING (period was abundant, with too much bleeding), OVULATION PAIN (period was very painful) and MENSTRUATION IRREGULAR (her period came a week earlier) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: pain in injection site during administration; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in injection site during administration) and MYALGIA (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 036A21A) for an unknown indication.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain in injection site during administration) and MYALGIA (sore arm). On 12-Apr-2021, VACCINATION SITE PAIN (pain in injection site during administration) had resolved. At the time of the report, MYALGIA (sore arm) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle discomfort, Myalgia, Pain in extremity, Vaccination site discomfort
Clinical narrative: injection site isn't really painful, and it isn't 24 hours a day; It goes down her leg when she is walking; every now and then she gets a muscular discomfort at the injection site; developed a really acute pain in lower back muscles, specially in her buttocks area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (injection site isn't really painful, and it isn't 24 hours a day), PAIN IN EXTREMITY (It goes down her leg when she is walking), MUSCLE DISCOMFORT (every now and then she gets a muscular discomfort at the injection site) and MYALGIA (developed a really acute pain in lower back muscles, specially in her buttocks area) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concurrent medical conditions included Seasonal allergy. Concomitant products included SIMVASTATIN for Stroke, FLUOXETINE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE DISCOMFORT (injection site isn't really painful, and it isn't 24 hours a day), PAIN IN EXTREMITY (It goes down her leg when she is walking), MUSCLE DISCOMFORT (every now and then she gets a muscular discomfort at the injection site) and MYALGIA (developed a really acute pain in lower back muscles, specially in her buttocks area). The patient was treated with NAPROXEN SODIUM at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (injection site isn't really painful, and it isn't 24 hours a day), PAIN IN EXTREMITY (It goes down her leg when she is walking) and MUSCLE DISCOMFORT (every now and then she gets a muscular discomfort at the injection site) outcome was unknown and MYALGIA (developed a really acute pain in lower back muscles, specially in her buttocks area) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that 5 days after vaccination, she developed an acute pain in lower back muscles, especially in her buttocks area. At first, she thought she pulled a muscle when she does her exercise but was still going on. Sometimes it subsided and came back with painful. She stated that it goes down to her leg when she is walking. She stated that the injection site was not painful, and it was not 24 hours a day, but every now and then she got a muscular discomfort at the injection site.  Patient stated that she has scheduled to receive the second dose on Thursday, 22-APR-2021.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Pyrexia
Clinical narrative: left arm where she received the shot hurts so much that she cannot lift it; headache; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020 and Headache (very bad headache from the COVID).    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (left arm where she received the shot hurts so much that she cannot lift it), HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Patient stated that she wanted to know whether she can take Tylenol for the fever and pain.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: bump at injection site; redness at injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (bump at injection site), VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PRURITUS (itching at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE SWELLING (bump at injection site), VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE SWELLING (bump at injection site), VACCINATION SITE ERYTHEMA (redness at injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown. Not Provided          No concomitant drugs were reported. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-074772 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074772:1st dose case
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Pain in extremity, Vertigo
Clinical narrative: vertigo, her whole head was spinning all day with room spinning around her; super tired and fatigue; arm was sore and bruised; arm was sore and bruised; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (arm was sore and bruised), VERTIGO (vertigo, her whole head was spinning all day with room spinning around her), PAIN IN EXTREMITY (arm was sore and bruised) and FATIGUE (super tired and fatigue) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), METHADONE, METFORMIN and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 08-Apr-2021 at 6:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced CONTUSION (arm was sore and bruised) and PAIN IN EXTREMITY (arm was sore and bruised). On 10-Apr-2021, the patient experienced FATIGUE (super tired and fatigue). On 11-Apr-2021, the patient experienced VERTIGO (vertigo, her whole head was spinning all day with room spinning around her). On 11-Apr-2021, CONTUSION (arm was sore and bruised) and PAIN IN EXTREMITY (arm was sore and bruised) had resolved. At the time of the report, VERTIGO (vertigo, her whole head was spinning all day with room spinning around her) and FATIGUE (super tired and fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Pain in extremity, Pyrexia
Clinical narrative: little bit of shortness of breath; fever; head is hurting; soreness of arm; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN IN EXTREMITY (soreness of arm), DYSPNOEA (little bit of shortness of breath), PYREXIA (fever) and HEADACHE (head is hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high and Blood cholesterol abnormal.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness of arm). On 13-Apr-2021, the patient experienced DYSPNOEA (little bit of shortness of breath), PYREXIA (fever) and HEADACHE (head is hurting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache and Fever, at an unspecified dose and frequency. On 13-Apr-2021, PAIN IN EXTREMITY (soreness of arm) had resolved. At the time of the report, DYSPNOEA (little bit of shortness of breath), PYREXIA (fever) and HEADACHE (head is hurting) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was Not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No concomitant medications were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rhinorrhoea, Throat irritation, Vaccination site erythema, Vaccination site pain
Clinical narrative: runny nose, tiredness and a scratchy throat; runny nose, tiredness and a scratchy throat; runny nose, tiredness and a scratchy throat; hot redness; soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose, tiredness and a scratchy throat), THROAT IRRITATION (runny nose, tiredness and a scratchy throat), FATIGUE (runny nose, tiredness and a scratchy throat), VACCINATION SITE ERYTHEMA (hot redness) and VACCINATION SITE PAIN (soreness on her arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness on her arm). On 25-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (hot redness). On 09-Apr-2021, the patient experienced RHINORRHOEA (runny nose, tiredness and a scratchy throat), THROAT IRRITATION (runny nose, tiredness and a scratchy throat) and FATIGUE (runny nose, tiredness and a scratchy throat). On 20-Mar-2021, VACCINATION SITE PAIN (soreness on her arm) had resolved. At the time of the report, RHINORRHOEA (runny nose, tiredness and a scratchy throat), THROAT IRRITATION (runny nose, tiredness and a scratchy throat), FATIGUE (runny nose, tiredness and a scratchy throat) and VACCINATION SITE ERYTHEMA (hot redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus, Vaccination site swelling
Clinical narrative: itched; bump at injection site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itched), VACCINATION SITE SWELLING (bump at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (itched), VACCINATION SITE SWELLING (bump at injection site) and INJECTION SITE ERYTHEMA (redness at injection site). At the time of the report, PRURITUS (itched), VACCINATION SITE SWELLING (bump at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-074767 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074767:2nd dose case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Peripheral coldness
Clinical narrative: her toes and feet were very cold; chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (her toes and feet were very cold) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure high.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PERIPHERAL COLDNESS (her toes and feet were very cold) and CHILLS (chills). At the time of the report, PERIPHERAL COLDNESS (her toes and feet were very cold) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported. Treatment information not provided.   This case was linked to MOD21-074180 (E2B Linked Report).; Sender's Comments:  MOD21-074180:MOD-2021-074782 -2nd dose of vaccine
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: red itch welt on injection arm; red itch welt on injection arm; red itch welt on injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red itch welt on injection arm), VACCINATION SITE URTICARIA (red itch welt on injection arm) and VACCINATION SITE ERYTHEMA (red itch welt on injection arm) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (red itch welt on injection arm), VACCINATION SITE URTICARIA (red itch welt on injection arm) and VACCINATION SITE ERYTHEMA (red itch welt on injection arm). At the time of the report, VACCINATION SITE PRURITUS (red itch welt on injection arm), VACCINATION SITE URTICARIA (red itch welt on injection arm) and VACCINATION SITE ERYTHEMA (red itch welt on injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment information was not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Peripheral swelling, Vaccination site rash
Clinical narrative: arm pain within 1st hour which lasted by weekend; size of her arm got bigger than other arm; under arm lymph node of same arm got swollen; rash on her bicep where injection was administered/rash spread down to her elbow; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend), PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 (suspects that she had covid in the past). Concurrent medical conditions included Food allergy (was allergic to some foods when she was a kid).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend), PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow). The patient was treated with CORTISONE at a dose of shot. At the time of the report, PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend) had resolved and PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Patient was given a cortisone shot on her second visit to urgent care which made her feel better.The patient received additional treatment with unspecified topical creams and ice pack. Patient is scheduled for 2nd dose on 17-APR-2021.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: fever; nausea; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), NAUSEA (nausea) and MYALGIA (body ache) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced PYREXIA (fever), NAUSEA (nausea) and MYALGIA (body ache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), NAUSEA (nausea) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Chest pain, Chills, Dysphonia, Headache
Clinical narrative: Chest pain; Losing the voice; vomiting; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Medical history was not provided by reporter.  Concomitant products included METFORMIN, INSULIN, LOSARTAN and GEMFIBROZIL for an unknown indication.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 446 (High) high( 446mg%).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Non-Significant Follow up appended. On 04-May-2021: Follow up received contain significant information. Event outcome updated from unknown to recovered. On 05-Aug-2021: Follow up received contain significant information. Patient took second dose information updated .
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chest pain; Losing the voice; vomiting; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Medical history was not provided by reporter.  Concomitant products included METFORMIN, INSULIN, LOSARTAN and GEMFIBROZIL for an unknown indication.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Chest pain), DYSPHONIA (Losing the voice), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 446 (High) high( 446mg%).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Non-Significant Follow up appended. On 04-May-2021: Follow up received contain significant information. Event outcome updated from unknown to recovered. On 05-Aug-2021: Follow up received contain significant information. Patient took second dose information updated .
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Decreased appetite, Dizziness
Clinical narrative: No appetite; coughing; Dizziness; Feeling weak; Itching in both arms; arm was little bit hard; Swelling in left arm, arm was little bit puffy; arm was little bit hard, little bit red; Swelling in left lymph node; Headache; Muscle ache; Sever fatigue; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak) and PRURITUS (Itching in both arms) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (was diagnosed with COVID and been experiencing COVID side effects for the last 5 months) since an unknown date. Concurrent medical conditions included Diabetic, Joint dysfunction, Heart disorder (30% of heart works) and High cholesterol. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), HEADACHE (Headache), MYALGIA (Muscle ache), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node), ERYTHEMA (arm was little bit hard, little bit red), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 11-Apr-2021, PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node) and ERYTHEMA (arm was little bit hard, little bit red) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), HEADACHE (Headache), MYALGIA (Muscle ache), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Induration, Lymphadenopathy
Clinical narrative: No appetite; coughing; Dizziness; Feeling weak; Itching in both arms; arm was little bit hard; Swelling in left arm, arm was little bit puffy; arm was little bit hard, little bit red; Swelling in left lymph node; Headache; Muscle ache; Sever fatigue; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak) and PRURITUS (Itching in both arms) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (was diagnosed with COVID and been experiencing COVID side effects for the last 5 months) since an unknown date. Concurrent medical conditions included Diabetic, Joint dysfunction, Heart disorder (30% of heart works) and High cholesterol. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), HEADACHE (Headache), MYALGIA (Muscle ache), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node), ERYTHEMA (arm was little bit hard, little bit red), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 11-Apr-2021, PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node) and ERYTHEMA (arm was little bit hard, little bit red) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), HEADACHE (Headache), MYALGIA (Muscle ache), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Peripheral swelling, Pruritus
Clinical narrative: No appetite; coughing; Dizziness; Feeling weak; Itching in both arms; arm was little bit hard; Swelling in left arm, arm was little bit puffy; arm was little bit hard, little bit red; Swelling in left lymph node; Headache; Muscle ache; Sever fatigue; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak) and PRURITUS (Itching in both arms) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (was diagnosed with COVID and been experiencing COVID side effects for the last 5 months) since an unknown date. Concurrent medical conditions included Diabetic, Joint dysfunction, Heart disorder (30% of heart works) and High cholesterol. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), HEADACHE (Headache), MYALGIA (Muscle ache), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node), ERYTHEMA (arm was little bit hard, little bit red), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 11-Apr-2021, PRURITUS (Itching in both arms), INDURATION (arm was little bit hard), PERIPHERAL SWELLING (Swelling in left arm, arm was little bit puffy), LYMPHADENOPATHY (Swelling in left lymph node) and ERYTHEMA (arm was little bit hard, little bit red) had resolved. At the time of the report, DECREASED APPETITE (No appetite), COUGH (coughing), DIZZINESS (Dizziness), ASTHENIA (Feeling weak), HEADACHE (Headache), MYALGIA (Muscle ache), FATIGUE (Sever fatigue), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Aches/pains; Headache; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN (Aches/pains) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN (Aches/pains) and HEADACHE (Headache). At the time of the report, PAIN (Aches/pains) and HEADACHE (Headache) outcome was unknown.            Concomitant product use was not provided by the reporter.   Reportedly, customer wanted to know if his son can take Tylenol (or any over-the-counter pain medication) and whether or not that would have an interference with the vaccine.  Treatment information was not provided.   This case was linked to MOD21-074690, US-MODERNATX, INC.-MOD-2021-075407 (E2B Linked Report).; Sender's Comments:  MOD21-074690: US-MODERNATX, INC.-MOD-2021-075407: